6 Results

People

  1. Konner
    Konner
  2. Levine
    Levine
  3. Aghajanian
    Aghajanian
  4. Desilets
    Desilets
  5. Dunn
    Dunn
  6. Emengo
    Emengo
  7. Fetten
    Fetten
  8. Friedman
    Friedman
  9. Ho
    Ho
  10. Hung
    Hung

Groups

  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. GDMT, Medicine (3)
  4. Gynecologic Medicine Service (3)
  5. Gynecology Disease Management Team (3)
  6. Surgery (2)
  7. Weinberg Fellows (2)
  8. Biostatistics Service (1)
  9. Epidemiology and Biostatistics (1)
  10. GME, Medicine (1)
  1. "platinum resistance"
Formats
  1. Journal Article (6)
Groups
  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. GDMT, Medicine (3)
  4. Gynecologic Medicine Service (3)
  5. Gynecology Disease Management Team (3)
  6. Surgery (2)

More Groups

People
  1. Douglas Levine (2)
  2. Jason Konner (2)
  3. Alan Ho (1)
  4. Alexia Iasonos (1)
  5. Antoine Desilets (1)
  6. Anuja Kriplani (1)

More People

Years
  1. 2024 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2014 (1)
  5. 2013 (1)
  6. 2010 (1)
Publications
  1. Gynecologic Oncology (2)
  2. Cancer (1)
  3. Future Oncology (1)
  4. Journal of Clinical Oncology (1)
  5. Oral Oncology (1)
Publishers
  1. Elsevier Inc. (3)
  2. American Society of Clinical Oncology (1)
  3. Future Medicine (1)
  4. Wiley Blackwell (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer
    Journal Article

    Desilets, A.; Pfister, D. G.; Stein, S.; Wong, W.; Sherman, E. J.; Fetten, J.; Hung, T. K. W.; Kriplani, A.; Dunn, L. A.; Ho, A. L.; more...
    Oral Oncology (2024)

    Fulltext@MSK | Save
  • Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer
    Journal Article

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Emengo, V. N.; Friedman, C.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer
    Journal Article

    Moore, K. N.; Martin, L. P.; O'Malley, D. M.; Matulonis, U. A.; Konner, J. A.; Vergote, I.; Ponte, J. F.; Birrer, M. J.
    Future Oncology (2018)

    Fulltext@MSK | Save
  • Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: Results of a randomized, double-blind, phase 2, parallel-arm study
    Journal Article

    Tew, W. P.; Colombo, N.; Ray Coquard, I.; Del Campo, J. M.; Oza, A.; Pereira, D.; Mammoliti, S.; Matei, D.; Scambia, G.; Tonkin, K.; more...
    Cancer (2014)

    Fulltext@MSK | Save
  • Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis
    Journal Article

    Lum, E.; Vigliotti, M.; Banerjee, N.; Cutter, N.; Wrzeszczynski, K. O.; Khan, S.; Kamalakaran, S.; Levine, D. A.; Dimitrova, N.; Lucito, R.
    Gynecologic Oncology (2013)

    Fulltext@MSK | Save
  • Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer
    Journal Article

    Konstantinopoulos, P. A.; Spentzos, D.; Karlan, B. Y.; Taniguchi, T.; Fountzilas, E.; Francoeur, N.; Levine, D. A.; Cannistra, S. A.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save